FIELD: medicine; pharmaceutics.
SUBSTANCE: invention relates to a conjugate of the general formula (I), which is used for the delivery of a drug substance through a biological membrane.
EFFECT: technical result is obtaining compounds and methods for transmembrane delivery of molecules.
1 cl, 20 ex, 57 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | 2015 |
|
RU2703416C2 |
| OLIGONUCLEOTIDE CONJUGATES | 2013 |
|
RU2653438C2 |
| MEDICAL DEVICES FOR DELIVERY OF SIRNA | 2011 |
|
RU2585138C2 |
| DOUBLE-CHAINED OLIGONUCLEOTIDE SPECIFIC TO CTGF GENE AND COMPOSITION CONTAINING IT FOR PREVENTION AND TREATMENT OF FIBROUS DISEASES AND DISEASES ASSOCIATED WITH RESPIRATORY SYSTEM | 2020 |
|
RU2807108C1 |
| COMPLEXES BASED ON MICRO-BUBBLES AND METHODS OF APPLICATION | 2012 |
|
RU2613321C2 |
| SELF-DELIVERED RNAI COMPOUNDS OF REDUCED SIZE | 2011 |
|
RU2615143C2 |
| TREATING SIRTIUN 1 (SIRT1)-RELATED DISEASES BY INHIBITON OF NATURAL ANTISENSE TRANSCRIPT | 2009 |
|
RU2551234C2 |
| LOW-MOLECULAR CONJUGATES FOR INTRACELLULAR DELIVERY OF BIOLOGICALLY ACTIVE COMPOUNDS | 2011 |
|
RU2629957C2 |
| CANCER IMMUNOTHERAPY | 2014 |
|
RU2744194C2 |
| COMPOSITION FOR TREATMENT OF CANCER ASSOCIATED WITH HPV INFECTION | 2013 |
|
RU2636003C2 |
